Annual CFO
-$70.71 M
+$18.63 M+20.85%
31 December 2023
Summary:
Pyxis Oncology annual cash flow from operations is currently -$70.71 million, with the most recent change of +$18.63 million (+20.85%) on 31 December 2023. During the last 3 years, it has fallen by -$60.63 million (-601.20%). PYXS annual CFO is now -3058.06% below its all-time high of -$2.24 million, reached on 31 December 2019.PYXS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$14.66 M
-$11.66 M-387.70%
30 September 2024
Summary:
Pyxis Oncology quarterly cash flow from operations is currently -$14.66 million, with the most recent change of -$11.66 million (-387.70%) on 30 September 2024. Over the past year, it has increased by +$2.92 million (+16.60%). PYXS quarterly CFO is now -612.40% below its all-time high of $2.86 million, reached on 30 June 2021.PYXS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$53.64 M
+$2.92 M+5.16%
30 September 2024
Summary:
Pyxis Oncology TTM cash flow from operations is currently -$53.64 million, with the most recent change of +$2.92 million (+5.16%) on 30 September 2024. Over the past year, it has increased by +$19.21 million (+26.37%). PYXS TTM CFO is now -237.99% below its all-time high of -$15.87 million, reached on 30 June 2021.PYXS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PYXS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.9% | +16.6% | +26.4% |
| 3 y3 years | -601.2% | -101.2% | -131.6% |
| 5 y5 years | - | - | - |
PYXS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -601.2% | +20.9% | -387.7% | +47.0% | -131.6% | +40.0% |
| 5 y | 5 years | -3058.1% | +20.9% | -612.4% | +47.0% | -238.0% | +40.0% |
| alltime | all time | -3058.1% | +20.9% | -612.4% | +47.0% | -238.0% | +40.0% |
Pyxis Oncology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$14.66 M(+387.7%) | -$53.64 M(-5.2%) |
| June 2024 | - | -$3.01 M(-85.5%) | -$56.55 M(-12.4%) |
| Mar 2024 | - | -$20.71 M(+35.8%) | -$64.58 M(-8.7%) |
| Dec 2023 | -$70.71 M(-20.8%) | -$15.25 M(-13.2%) | -$70.71 M(-2.9%) |
| Sept 2023 | - | -$17.58 M(+59.4%) | -$72.84 M(-3.9%) |
| June 2023 | - | -$11.03 M(-58.9%) | -$75.82 M(-14.3%) |
| Mar 2023 | - | -$26.84 M(+54.4%) | -$88.50 M(-0.9%) |
| Dec 2022 | -$89.33 M | -$17.39 M(-15.4%) | -$89.33 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$20.56 M(-13.3%) | -$84.12 M(+18.7%) |
| June 2022 | - | -$23.71 M(-14.3%) | -$70.85 M(+60.0%) |
| Mar 2022 | - | -$27.68 M(+127.5%) | -$44.27 M(+25.3%) |
| Dec 2021 | -$35.33 M(+250.3%) | -$12.17 M(+67.0%) | -$35.33 M(+52.5%) |
| Sept 2021 | - | -$7.29 M(-354.6%) | -$23.16 M(+45.9%) |
| June 2021 | - | $2.86 M(-115.3%) | -$15.87 M(-15.3%) |
| Mar 2021 | - | -$18.73 M | -$18.73 M |
| Dec 2020 | -$10.08 M(+350.4%) | - | - |
| Dec 2019 | -$2.24 M | - | - |
FAQ
- What is Pyxis Oncology annual cash flow from operations?
- What is the all time high annual CFO for Pyxis Oncology?
- What is Pyxis Oncology annual CFO year-on-year change?
- What is Pyxis Oncology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Pyxis Oncology?
- What is Pyxis Oncology quarterly CFO year-on-year change?
- What is Pyxis Oncology TTM cash flow from operations?
- What is the all time high TTM CFO for Pyxis Oncology?
- What is Pyxis Oncology TTM CFO year-on-year change?
What is Pyxis Oncology annual cash flow from operations?
The current annual CFO of PYXS is -$70.71 M
What is the all time high annual CFO for Pyxis Oncology?
Pyxis Oncology all-time high annual cash flow from operations is -$2.24 M
What is Pyxis Oncology annual CFO year-on-year change?
Over the past year, PYXS annual cash flow from operations has changed by +$18.63 M (+20.85%)
What is Pyxis Oncology quarterly cash flow from operations?
The current quarterly CFO of PYXS is -$14.66 M
What is the all time high quarterly CFO for Pyxis Oncology?
Pyxis Oncology all-time high quarterly cash flow from operations is $2.86 M
What is Pyxis Oncology quarterly CFO year-on-year change?
Over the past year, PYXS quarterly cash flow from operations has changed by +$2.92 M (+16.60%)
What is Pyxis Oncology TTM cash flow from operations?
The current TTM CFO of PYXS is -$53.64 M
What is the all time high TTM CFO for Pyxis Oncology?
Pyxis Oncology all-time high TTM cash flow from operations is -$15.87 M
What is Pyxis Oncology TTM CFO year-on-year change?
Over the past year, PYXS TTM cash flow from operations has changed by +$19.21 M (+26.37%)